Orion Market Research
GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND FORECAST 2018-2023
DEFINITION The global bone cancer diagnosis and therape utics market is anticipated to grow at a CAGR of 7.8% by 2023. Several factors such as expo sure towards radiation, factures, treatment fo r certain cancer related drugs, and genetic dis orders cause bone cancer.
MARKET MOTIVATORS • Robust healthcare expenditure in the developed economies • Exposure towards radioactive material • Rising geriatric population • Increasing incidence of paget diseases among individuals • Stem cell transplants technology
MARKET RESTRAINTS • Lack of awareness towards diagnosis and therapeutics in developing and under developed nations • High cost of treatment
MARKET SEGMENTATION BY TYPE • Primary bone cancer • Secondary bone cancer
MARKET SEGMENTATION BY THERAPIES
Radiation therapies Chemotherapy Cryosurgery Surgical treatment Targeted therapy Others
MARKET SEGMENTATION BY END USER
Multispecialty hospitals
Cancer research centers
MARKET SEGMENTATION BY DIAGNOSIS • Mri scans • X-rays • Ct-scan • Radionuclide bone sensors • Biopsy • Others
REGIONAL OVERVIEW
North America
Europe
Asia-Pacific
Rest of the World
MARKET PLAYERS • • • • • • • •
Ablynz Allergan Aveo Pharmaceuticals, Inc. Amgen Inc. Amura Holdings Ltd. Bayer AG Catena Pharmaceuticals Inc. Celldex Therapeutics
To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com
https://www.omrglobal.com/industry-reports/bone-cancer-diagnosis-and-therapeutics-market/